Whalestream has ceased operations permanently

Healthcare Sector

MRK

Market Tracker

$123.92
-1.15
(-0.92%)
2:36 am
Next Earnings: (est.) 08/01/23 12:00 am
  • MRK (Selected)

    Merck & Co., Inc.
  • MRK#

    Merck & Co., Inc. (MRK
  • MRKR

    Marker Therapeutics, Inc.

MRK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/17/2026 PUT $126.00 795 +705 +783.33%
09/18/2026 CALL $150.00 1,987 +612 +44.51%
09/18/2026 CALL $130.00 5,723 +546 +10.55%
07/10/2026 CALL $130.00 1,825 +456 +33.31%
07/17/2026 PUT $123.00 347 +300 +638.30%
07/10/2026 PUT $106.00 299 +272 +1,007.41%
01/21/2028 CALL $80.00 120 -36 -23.08%
09/18/2026 PUT $110.00 5,240 -38 -0.72%
07/17/2026 PUT $110.00 2,558 -46 -1.77%
09/18/2026 PUT $75.00 2,145 -49 -2.23%
07/17/2026 CALL $130.00 5,930 -71 -1.18%
01/15/2027 CALL $120.00 5,490 -208 -3.65%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRK Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.04% 77.07M 8.28B
Vanguard 500 Index Fund 2.31% 58.61M 6.3B
Fidelity 500 Index Fund 1.09% 27.79M 2.99B
SPDR S&P 500 ETF Trust 1.08% 27.45M 2.95B
iShares Core S&P 500 ETF 0.89% 22.63M 2.43B
Vanguard Index-Value Index Fund 0.86% 21.91M 2.35B
Select Sector SPDR Fund-Health Care 0.81% 20.59M 2.21B
Vanguard Specialized-Health Care Fund 0.72% 18.31M 1.97B
Vanguard Institutional Index Fund-Institutional Index Fund 0.70% 17.77M 1.91B
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF 0.68% 17.38M 1.87B

MRK News

  • Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

    07/09 08:15 am

    The Motley Fool

    Read more
  • BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?

    07/08 07:28 am

    The Motley Fool

    Read more
  • The Dividend ETF Quietly Outperforming the S&P 500

    07/07 05:30 am

    The Motley Fool

    Read more
  • Moderna Stock Is Soaring. Is It Too Late to Buy?

    07/07 05:15 am

    The Motley Fool

    Read more
  • 3 Dividend ETF Picks That Could Build Serious Long-Term Wealth

    07/05 05:20 pm

    The Motley Fool

    Read more
  • Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

    07/03 11:14 am

    The Motley Fool

    Read more
  • Want Decades of Passive Income? Buy This ETF and Hold It Forever.

    07/03 07:27 am

    The Motley Fool

    Read more
  • Big Pharma Has a Case of Merger Mania

    06/30 12:26 am

    The Motley Fool

    Read more
  • Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight

    06/24 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda

    06/23 08:00 am

    GlobeNewswire Inc.

    Read more
  • Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight

    06/22 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

    06/20 07:30 am

    The Motley Fool

    Read more
  • Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

    06/18 07:09 pm

    The Motley Fool

    Read more
  • FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens

    06/18 11:29 am

    Benzinga

    Read more
  • 3 Dividend Stocks to Hold for the Long Haul

    06/16 06:15 am

    The Motley Fool

    Read more
  • Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

    06/10 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial

    06/09 01:44 pm

    Benzinga

    Read more
  • Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy?

    06/08 05:23 pm

    The Motley Fool

    Read more
  • Global Sustainability Awards 2026 Opens Final Call for Entries as Industry Leaders Prepare to Celebrate Sustainability Excellence

    06/02 09:00 am

    GlobeNewswire Inc.

    Read more
  • Moderna Reports Strong 5-Year Cancer Vaccine Data, Expands CEPI Partnership; Stock Falls

    06/01 12:39 pm

    Benzinga

    Read more
  • Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%

    05/29 08:27 pm

    The Motley Fool

    Read more
  • Glioblastoma Multiforme Market Poised for Significant Growth at a CAGR of 13.2% During the Forecast Period (2026–2036), as Next-Generation Therapies Enter Late-Stage Development | DelveInsight

    05/27 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Therini Bio Doses First Patients in Phase 1b Trial of Novel Anti-Inflammatory Therapy, THN391, for Diabetic Macular Edema

    05/27 10:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Dividend Stocks to Hold for the Next 10 Years

    05/25 01:23 pm

    The Motley Fool

    Read more
  • S&P 500 Rally Defies Weak Sentiment and Hawkish Fed Signals

    05/22 12:04 pm

    Investing.com

    Read more
  • Oorja Bio Launches as a Clinical-Stage Company to Develop Groundbreaking Therapies for Idiopathic Pulmonary Fibrosis (IPF) and Other Fibrotic Diseases

    05/19 03:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Is Regeneron Stock Sinking Monday?

    05/18 06:28 am

    Benzinga

    Read more
  • Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report

    05/15 11:47 am

    Benzinga

    Read more
  • Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

    05/13 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab)

    05/11 07:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Dividend Stocks to Double Up On Right Now

    05/08 01:30 pm

    The Motley Fool

    Read more
  • Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary

    05/06 07:00 am

    GlobeNewswire Inc.

    Read more
  • InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics

    05/01 08:00 am

    GlobeNewswire Inc.

    Read more
  • Merck Swings To Quarterly Loss On Cidara Deal

    04/30 01:10 pm

    Benzinga

    Read more
  • Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - Analyst Recommendations and Global Forecast to 2031

    04/28 10:00 am

    GlobeNewswire Inc.

    Read more
  • Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence

    04/28 03:52 am

    GlobeNewswire Inc.

    Read more
  • Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal

    04/27 05:34 pm

    The Motley Fool

    Read more
  • AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation

    04/27 01:36 pm

    GlobeNewswire Inc.

    Read more
  • Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight

    04/27 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 3 Biotech Stocks That Could Benefit from the Patent Cliff

    04/27 11:29 am

    Investing.com

    Read more
  • Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges

    04/22 02:20 pm

    Benzinga

    Read more
  • Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight

    04/22 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca

    04/22 05:59 am

    GlobeNewswire Inc.

    Read more
  • Why Is Merck Stock Falling Tuesday?

    04/21 01:42 pm

    Benzinga

    Read more
  • Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight

    04/21 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights

    04/21 04:14 am

    GlobeNewswire Inc.

    Read more

🎁

Take 50% OFF With Code: